Pharmaceutical preparations and substances.

Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of osteoporosis

Préparations pharmaceutiques.

Trousers; suits; jackets; coats; cardigans; blouses

Car stereos; docking stations for cell phones; earphones; wireless headsets for use with smartphones; hands-free microphones for cell phones; docking stations for laptops; USB cables for cellular phones; USB chargers; 3D spectacles; computer keyboards; computer mice; computer speakers; home cinema projectors; selfie stick; audio/video cables; bicycle helmets; electronic control gears [ECGs] for LED lamps and light fixtures; cases for smartphones; camera tripods; computer cables

Belts for farm vehicle machines; belts for machines; belts for motors and engines; carburetors; carburetter feeders; clutches for industrial machinery; engine fuel pumps; filters for cleaning cooling air for engines; gaskets for engines; ignition devices for motors of land vehicles; ignition magnetos for engines; ignitions for vehicles; internal combustion engines for boats; metal engine gaskets for vehicles; starters for motors and engines

Electric relays; voltage regulators

Pharmaceutical preparations for the treatment of cancer; Medicines for human use for the treatment of cancer; Antibodies for the treatment of cancer; Biological preparations for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Drugs for the treatment of cancer; Monoclonal antibodies for medical use; Pharmaceutical drugs for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical products for the treatment of cancer.

Pharmaceutical preparations for the treatment of cancer; Medicines for human use for the treatment of cancer; Antibodies for the treatment of cancer; Biological preparations for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Drugs for the treatment of cancer; Monoclonal antibodies for medical use; Pharmaceutical drugs for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical products for the treatment of cancer.

Pharmaceutical and veterinary preparations for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); biological preparations for medical purposes namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); biochemical preparations for medical purposes namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); chemical preparations for pharmaceutical purposes namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); medical preparations of trace elements for human and animal use namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); ferments for use as pharmaceutical preparations for general health and wellbeing; biotechnological preparations for medical purposes namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); chemical preparations for medicinal purposes namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); chemical preparations for medical or veterinary purposes namely for the treatment of central nervous system diseases, cancer and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); chemical preparations for sanitary use for preventing pathogenic infections in humans and animals; pharmaceutical preparations for immunity adjustment namely immunomodulatory; vitamin preparations; vaccines for bacterial, fungal, viral and parasitic infections; dietary supplements for general health and wellbeing; therapeutic drugs and agents namely the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); chemico-pharmaceutical preparations namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x); bacteriological preparations for medical and veterinary use namely for the treatment of cancer, central nervous system diseases namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, alzheimer's, cerebral palsy, parkinson's disease, arachnoid cysts, attention deficit hyperactivity disorder(adhd), autism, bipolar disorder, catalepsy, depression, encephalitis, epilepsy, seizures, locked-in syndrome, meningitis, migraines, multiple sclerosis, myelopathy, neurodegenerative disorders, alzheimer's, huntington's disease, parkinson's, tourettes', anxiety, smoking, obesity, sleep disorders, neuropathic pain, cognitive impairment, schizophrenia, neurodegeneration and centrally acting muscle spasm, and metabolic diseases namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperthyroidism, hypothyroidism, dyslipidemia, hypolipidemia, galatosemia, phenylketonuria, steroid induced diabetes, human immunodeficiency virus (hiv) treatment-induced diabetes, latent autoimmune diabetes in adults (lada), nonalcoholic steatohepatitis (nash), nonalcoholic fatty liver disease (nafld), hypoglycemia unawareness (ha), restrictive lung disease, diabetes development in subjects with congenital or hiv-associated lipoatrophy, fat redistribution syndrome, and metabolic syndrome (syndrome x)

Pharmaceutical preparations for human use